Characterization of GE discovery IGS 740 angiography system by means of channelized Hotelling observer (CHO)
The aim of the study is to use the well-known channelized Hotelling observer model (CHO) to characterize a recently installed angiography system (GE Discovery IGS 740) using sets of images of a contrast-detail phantom acquired with clinical protocols. A Leeds TO10 phantom was used. The phantom has 1...
Gespeichert in:
Veröffentlicht in: | Physics in medicine & biology 2019-04, Vol.64 (9), p.095002-095002 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The aim of the study is to use the well-known channelized Hotelling observer model (CHO) to characterize a recently installed angiography system (GE Discovery IGS 740) using sets of images of a contrast-detail phantom acquired with clinical protocols. A Leeds TO10 phantom was used. The phantom has 108 details: 12 diameters (size range: 0.25 mm-11 mm), each with nine contrasts (declared range: 0.012-0.930 at 70 kVp 1.00 with 1 mm Cu filtration). TO10 has been imaged between two 10 cm thick homogeneous solid water slabs. Two FOVs (32 cm and 20 cm) were used. Fluoroscopy images were taken using an abdominal protocol at two different frame rates (15 fps and 7.5 fps) and at two dose levels (low and normal); cineangiography images were acquired using an abdominal protocol at 15 fps at two dose levels (low and normal). A 40 Gabor channels CHO with internal noise was used. Human observers' studies were carried out to tune the internal noise parameter and to validate the model observer. Contrast-detail curves were obtained from the CHO output using a visibility threshold of 75% and fitted with Rose's model theory in order to characterize the angiography system. Wilcoxon rank-sum tests were performed to investigate possible differences among the different sets of images. The CHO can distinguish between the two dose levels (p -values |
---|---|
ISSN: | 0031-9155 1361-6560 1361-6560 |
DOI: | 10.1088/1361-6560/ab144c |